VALNIVUDINE HYDROCHLORIDE
Shingles
ContraVir Pharmaceuticals, Inc.Small moleculePhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Shingles cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Capsaicin NeurogesX | Phase 3 | BBB |
Zoster Vaccine Recombinant, Adjuvanted GlaxoSmithKline | Phase 4 | BBB |
ZOSTER VACCINE, LIVE, (OKA/MERCK) Louis Stokes VA Medical Center | Phase 4 | BBB |
Pregabalin CMH Kharian Medical College | Phase 4 | BB |
Gabapentine Dominik Irnich | Phase 4 | BB |
View all 26 →
Same molecule, other indications
VALNIVUDINE HYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →